Schott Extends License to Accelr8's Microarray Slide-Coating Technology | GenomeWeb
NEW YORK (GenomeWeb News) — Accelr8 today said it has extended a
licensing agreement with Schott  Nexterion that allows Schott to use its surface-coating chemistry to make and market microarray slides.
 
Under the new two-year agreement, Schott will have access to a version of Accelr8’s OptiChem product to produce its Slide HS microarraying slides.
 
The OptiChem technology uses a protein to create an even and stable slide surface, according to Accelr8.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.